Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

186.26 -2.61 (-1.38%)
Official Closing Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
Johnson & Johnson (NYSE:JNJ) Stands Out as a Top Dividend Stock with Strong Fundamentals
Discover Johnson & Johnson (JNJ), a top dividend stock with a strong 2.91% yield, consistent growth, and solid financial health for reliable income. 
Via Chartmill
U.S. Leading Economic Index Dips: A Harbinger of Economic Slowdown or a False Alarm?
The U.S. Leading Economic Index (LEI) has experienced a consistent decline in recent months, sparking concerns about the nation's economic trajectory for the second half of 2025. While the current... 
Via MarketMinute
Topics Economy Supply Chain World Trade
Top 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cuts
Powell’s dovish Jackson Hole remarks signal that the Fed could cut rates as early as September, with markets now pricing an 80% chance of a 25 bps cut. 
Via MarketBeat
Topics ETFs Economy
This Pharma Giant Is Set To Invest $2B To Expand Manufacturing In North Carolina, And It Just Received A Price Target Hike From Citi: Do You Own It?
Via Stocktwits
Bridgewater, Once Led By Ray Dalio, Exits Alibaba, JD, PDD And Baidu, Dumping All US-listed Chinese Stocks Amid Geopolitical Risks
Bridgewater's Q2 filing shows a full exit from Chinese stocks like Alibaba, as new management bets big on NVIDIA & JNJ. See all the shifts. 
Via Benzinga
3 Dividend Growth Leaders to Buy Now
Via MarketBeat
Topics ETFs Economy World Trade
JNJ Stock Surge Signals Confidence in New Growth Path
Johnson & Johnson's strategic shift to a focused pharma and medtech model is fueling growth through a powerful drug pipeline and key acquisitions. 
Via MarketBeat
Topics Lawsuit
Got $500? 3 Dividend Stocks to Buy and Hold Forever
If you're looking for income stocks, this trio of healthcare stocks is a great place to start with $500 (or $5,000). 
Via The Motley Fool
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Growth stocks are dominating the S&P 500, pushing the index's dividend yield to a 25-year low. 
Via The Motley Fool
Topics ETFs Stocks
2 Dividend Stocks Worth Doubling Down on Right Now
These healthcare giants can survive the toughest challenges. 
Via The Motley Fool
Topics World Trade
The "Ten Titans" Stocks Now Make Up 38% of the S&P 500. Here's What It Means for Your Investment Portfolio
Massive growth stocks are driving the performance of the S&P 500, for better or for worse. 
Via The Motley Fool
Topics Economy Stocks
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Investors looking to double down on mega cap stocks like the "Ten Titans" may want to take a closer look at this low-cost ETF. 
Via The Motley Fool
Topics ETFs Stocks
Navigating the Peaks and Valleys: A Deep Dive into US Equity Market Valuations
The US equity market in mid-2025 presents a complex and often contradictory landscape for investors. While the S&P 500 has flirted with all-time highs, fueled by optimistic economic data and the... 
Via MarketMinute
Topics Artificial Intelligence Economy Energy
U.S. Economy Navigates Divergent Signals: Downward Revisions for 2025 Clash with Stronger Q3 Outlook
The U.S. economy finds itself at a crossroads, grappling with a complex interplay of growth projections. Recent downward revisions for 2025, coupled with a notable contraction in the first quarter of... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs
Johnson & Johnson (NYSE: JNJ) is set to invest $2 billion in its North Carolina facilities, expanding its U.S. manufacturing operations. This move comes in response to potential drug import tariffs... 
Via Benzinga
Topics Government World Trade
3 Stable Dividend-Paying Stocks That Are Perfect for Retirees
Names you've heard of with track records to love. 
Via The Motley Fool
Topics Retirement
9 Analysts Have This To Say About Johnson & Johnson
 
Via Benzinga
How Do Investors Really Feel About Johnson & Johnson?
 
Via Benzinga
Congressional Trading Report: Rep. Thomas Kean Sold Over $31K In Johnson & Johnson Stock
 
Via Benzinga
Sender Buys Into the Turnaround Story at Kenvue
Via The Motley Fool
Topics Regulatory Compliance
Market's Muted Ascent: A Cautious Calm Near Record Highs
Despite hovering at or near all-time highs, the major U.S. stock indices—the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite—have recently displayed a remarkably subdued daily performance.... 
Via MarketMinute
Topics Economy Stocks World Trade
The Unsettling U: U.S. Treasury Yield Curve Signals Market Standoff and Economic Crossroads
The U.S. Treasury yield curve has contorted into a rare and unsettling U-shape, a configuration seen in only a fraction of the past five decades. This unusual curve, characterized by high short-term... 
Via MarketMinute
Topics Bonds Credit Cards Economy
Wall Street Holds Its Breath: Awaiting Powell's Verdict Amidst Pervasive Caution
Wall Street is currently gripped by a palpable "wait-and-see" sentiment, as investors adopt an overwhelmingly cautious stance ahead of Federal Reserve Chair Jerome Powell's highly anticipated speech at... 
Via MarketMinute
Topics Economy Stocks
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Economic Barometer: Consumer Spending and Labor Market Trends Under Scrutiny
The global financial landscape is currently navigating a period of heightened uncertainty, with key economic indicators signaling a notable deceleration in private consumption and emerging fragilities... 
Via MarketMinute
Topics Economy World Trade
Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm
These companies have successfully navigated similar obstacles before. 
Via The Motley Fool
Topics Intellectual Property
These Are the 3 Smartest Dividend Stocks Today
These three dividend stocks offer steady income and a history of delivering through thick and thin. 
Via The Motley Fool
Topics Economy
Federal Reserve Rate Cut Hopes Dwindle as Stubborn Inflation Surges Post-PPI
Washington D.C. – Hopes for an imminent Federal Reserve interest rate cut have significantly dimmed following the release of hotter-than-expected Producer Price Index (PPI) data on August 14, 2025. The... 
Via MarketMinute
Topics Bonds Economy Stocks
Sector Rotation in Full Swing: Cyclical Stocks Gain Favor as Investors Shift from Tech
The financial markets are currently experiencing a significant sector rotation, as investors increasingly shift their capital from growth-oriented technology stocks towards more value-driven cyclical... 
Via MarketMinute
Topics Economy
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.